Skip to Main content Skip to Navigation
Journal articles

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

Abstract : The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of aminoquinolines have been investigatedin vitro, in vivoand in clinical trials for more than 30 years. We review the mechanisms of action of (hydroxy)chloroquine on immune cells and networks and discuss promises and pitfalls in the fight against SARS-CoV-2, the agent of the COVID-19 outbreak.
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03149722
Contributor : Isabelle Combe <>
Submitted on : Tuesday, February 23, 2021 - 11:53:53 AM
Last modification on : Wednesday, March 17, 2021 - 9:26:04 AM

Links full text

Identifiers

Collections

Citation

Joana Vitte, Moise Michel, Soraya Mezouar, Aissatou Bailo Diallo, Asma Boumaza, et al.. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. FRONTIERS IN IMMUNOLOGY, 2020, 11, ⟨10.3389/fimmu.2020.02159⟩. ⟨hal-03149722⟩

Share

Metrics

Record views

10